Lineage of origin in rhabdomyosarcoma informs pharmacological response - Wikidata - wikimedia - TriplyDB

Lineage of origin in rhabdomyosarcoma informs pharmacological response

Lineage of origin in rhabdomyosarcoma informs pharmacological response

http://www.wikidata.org/entity/Q30411722

about

The case for primary salivary rhabdomyosarcoma Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma.Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements Modeling of the human alveolar rhabdomyosarcoma Pax3-Foxo1 chromosome translocation in mouse myoblasts using CRISPR-Cas9 nuclease.Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma.Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors.A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies.Alveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options.Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma.Uncovering metabolism in rhabdomyosarcoma.PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1.Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors.P/CAF mediates PAX3-FOXO1-dependent oncogenesis in alveolar rhabdomyosarcoma.Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis.Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma.Molecular diagnostics in the management of rhabdomyosarcoma.Therapeutic applications of histone deacetylase inhibitors in sarcoma.NFκB signaling in alveolar rhabdomyosarcoma.A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo.

P2860

Q28081814-CA5E0F5A-FB26-4A5F-9141-CEA6F0141925 Q28389770-296AAA48-BA16-45DA-8493-4489CD31C621 Q30275551-8B79AE44-6BEF-4286-84A3-CDF216A47D7E Q30855713-658541FD-DDDF-4CE5-BC8A-1D1D75DC6B1E Q35058021-52D6684F-AA37-4983-A09D-C80B8C7DBC08 Q35861006-78A8BC41-4C3D-4BD7-8DC5-76664C80D8AF Q36142754-ABB75EE0-A1B3-4446-A87C-FE5D552D9F5E Q36201075-B18E8700-ABD3-4721-8B47-31EB92D585E0 Q36367000-4C8A3D4B-AA77-44B7-AD83-D266F48BDB54 Q37564708-8DCC4CF6-9594-4DB3-BA10-15BD2038CAC7 Q38297328-3EEA8E8B-F1F3-4E17-9F1B-92D31D45412A Q38553827-E8B8AD63-1C88-4674-9AA0-FC1C8DAF4F20 Q38730193-A1CC385C-0880-434F-BF9F-FFF040EDCA1A Q38733122-296EF43C-6E94-4A56-85E3-4A112033DFC2 Q38740103-F0AE812A-B792-493C-BF4B-18F102670DE5 Q38753542-D702DB51-D997-4C49-BAF1-D98B2E43FE68 Q38834036-D32CDD68-0C05-4E53-8DE7-BEEB0F7B06D4 Q38893243-97344C01-ABD8-422B-98EF-34F45F794BD6 Q39069676-8C6119AC-3329-4CBB-8627-DD70415E35AC Q39450827-53564CE5-44EE-49C9-AD37-44F4A9037584 Q41664774-803DFF24-32A4-4EF9-BFAD-83D8B2CCBD7D Q46456978-BDEB4507-626D-43DF-8C86-CC4BCE79EFDF

P2860

Lineage of origin in rhabdomyosarcoma informs pharmacological response

http://www.wikidata.org/entity/Q30411722

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Lineage of origin in rhabdomyosarcoma informs pharmacological response

@ast

Lineage of origin in rhabdomyosarcoma informs pharmacological response

@en

type

label

Lineage of origin in rhabdomyosarcoma informs pharmacological response

@ast

Lineage of origin in rhabdomyosarcoma informs pharmacological response

@en

prefLabel

Lineage of origin in rhabdomyosarcoma informs pharmacological response

@ast

Lineage of origin in rhabdomyosarcoma informs pharmacological response

@en

P1433

Q30411722-87F59F2D-A2D6-4FC6-9A08-0C68216CE253

P1476

Q30411722-2C50B12C-71E3-4D32-A30C-59D42F429B8E

P2093

Q30411722-00A146A1-A4D5-4CDC-B32C-578F5DFF5984

Q30411722-0DFAD756-402F-4133-A300-B5C7EAC7EFE7

Q30411722-12D524FA-502C-464B-9C8C-0EEE17CD2CCC

Q30411722-2065292A-131A-4FA1-BD99-142CC3248776

Q30411722-222A5B22-723C-4087-9C91-9D2A5D9C3F7E

Q30411722-29B3DE3E-37B0-4CC3-854D-5EECA70102FC

Q30411722-2C0346E8-FCA2-4AB1-A625-232126DFE9EA

Q30411722-3AC2BEDB-7483-4FD9-BAEB-181907C2FFF4

Q30411722-6E0D0448-86D5-439B-8A2C-C03BFBA82A05

Q30411722-7A862F2B-600E-4EC7-BD0A-831A886A60B5

P2860

Q30411722-00ED4E38-71BC-49B9-AD42-669F050DCBD2

Q30411722-02B72A3F-F50E-435E-B5AD-7BACCB7AF010

Q30411722-09157030-C283-498F-8622-9BBA898488E2

Q30411722-24B077F7-7193-4E17-A1CA-6CECC0F19FA4

Q30411722-2D0F4CFF-21A6-4AE6-824C-DA608A1B1B0B

Q30411722-2E12AC7C-B80E-47D4-9D4B-DD0C219E7C96

Q30411722-2F5F7213-B6E6-4234-AB5B-B1454FFC974C

Q30411722-3646D453-98B6-498E-A2AB-30E872C4800A

Q30411722-389CFDD7-F6FE-467B-9FAC-77FE166403B0

Q30411722-3F436C20-CA75-49A4-BFFB-BF11D722B0DA

P304

Q30411722-78E8FF22-4DEA-4131-9F3E-856836226439

P31

Q30411722-D2032247-152D-4892-BC97-AF15795A544A

P356

Q30411722-F6F2011C-B8DF-4439-A8DD-3830E96FD9C3

P433

Q30411722-9FE23D81-655B-4DA0-91FE-085A64CCC698

P478

Q30411722-38DB1DBA-4C79-4C1A-9E47-ADADFB473D3C

P50

Q30411722-EF6E3FA5-BA9F-49AC-9936-8BD31A2ABC27

Q30411722-FA78ED78-E669-4BE9-9AB0-D660336DCD2E

P577

Q30411722-038418B0-1D0F-4DD3-A450-3066DC8B7A45

P5875

Q30411722-D6D927D2-C883-45C7-83CE-00518D5CF1CE

P698

Q30411722-7AB4EFDA-8B66-43CF-9299-6329B90D7A15

P921

Q30411722-E19E6139-2051-4152-9B3A-0E32A9E7DFBB

P932

Q30411722-960F4087-3EC0-4460-8BC2-147588A1E281

P356

P1433

Genes & Development

P1476

Lineage of origin in rhabdomyosarcoma informs pharmacological response

@en

P2093

Amanda T McCleish

http://www.w3.org/2001/XMLSchema#string

Amy J Wagers

http://www.w3.org/2001/XMLSchema#string

Andrew S Brack

http://www.w3.org/2001/XMLSchema#string

Atiya Mansoor

http://www.w3.org/2001/XMLSchema#string

Benjamin R Ehler

http://www.w3.org/2001/XMLSchema#string

Brian P Rubin

http://www.w3.org/2001/XMLSchema#string

Charles Keller

http://www.w3.org/2001/XMLSchema#string

Christopher R R Bjornson

http://www.w3.org/2001/XMLSchema#string

David M Langenau

http://www.w3.org/2001/XMLSchema#string

Elaine T Huang

http://www.w3.org/2001/XMLSchema#string

P2860

PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells

Sources of variability and effect of experimental approach on expression profiling data interpretation

Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas

Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma

Generalized lacZ expression with the ROSA26 Cre reporter strain

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group

Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas

Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma

Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1.

Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies

P304

1578-1591

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/GAD.238733.114

http://www.w3.org/2001/XMLSchema#string

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Thomas A. Rando

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264632975

http://www.w3.org/2001/XMLSchema#string

P698

25030697

http://www.w3.org/2001/XMLSchema#string

P921

P932

4102765

http://www.w3.org/2001/XMLSchema#string